The Role of the Endometrial Immune Profile in Fertility Success:
Insights from the Im Map® Test

Reproductive immunology is emerging as a key field in the treatment of infertility, where the study of the endometrial immune profile is of particular relevance. A recent study by Singh et al. highlights the importance of this approach, underlining that detailed analysis of the endometrial immune system can be decisive for successful pregnancy in cases of infertility. This article explores how the Im Map® test, available at, fits into this context, offering an accurate assessment of endometrial immune status.
Moffet 2023 - Local immune recognition of trophoblast in early human pregnancy controversies and questions

Importance of Endometrial Immunological Study in Fertility


Singh et al’s research emphasises that analysis of the endometrial immune profile, in particular uNK (uterine natural killer) cells, is critical to understanding infertility. This study also suggests that the study of pNK cells (peripheral natural killer cells) may not be sufficient to discern between fertile women and those with recurrent implantation failure (RIF). Therefore, a more detailed and specific approach, such as that provided by the Im Map® test, is crucial to determine the most appropriate line of treatment.


Test Im Map®: Advanced Assessment for Personalised Treatment


The Im Map® test performs a comprehensive assessment of immune cells in the endometrium, providing a holistic view of the immune environment that may affect embryo implantation. This detailed analysis is vital for developing personalised treatment strategies, especially in women with RIF, where immune balance may be a key factor. The test provides a sound scientific basis for immunotherapy, increasing the chances of a successful pregnancy.


Advanced Endometrial Immune Profile Assessment


The Im Map® test is a diagnostic tool that analyses the immune subpopulations present in the endometrium. By identifying alterations in these immune profiles, Im Map® allows physicians to establish personalised treatments to restore immune balance. This is particularly relevant in cases of implantation failure and recurrent miscarriages, where a dysregulated immune response may be a contributing factor.


Clinical Applications and Benefits of the Im Map® Test


The Im Map® test is particularly beneficial for women with a history of infertility, especially those with cases of RIF or recurrent miscarriages. By identifying specific imbalances in the endometrial immune system, this test allows fertility specialists to adjust treatments more precisely and effectively. This not only increases the likelihood of pregnancy, but also helps to avoid unnecessary or ineffective treatments.





The endometrial immune profile is a critical component in the treatment of infertility, and the Im Map® test presents itself as an invaluable tool in this process. This test not only provides a deeper understanding of the causes of infertility, but also paves the way for more personalised and successful treatments. With the Im Map® test, couples face a brighter future in their quest for a healthy pregnancy.